Scientific article
Editorial
OA Policy
English

Predictive factors of treatment persistence in rheumatoid arthritis

Published in

Joint, Bone, Spine

Publication date

2020

Abstract

1. Introduction. Randomised controlled trials (RCTs) are considered the “gold standard” to establish drug efficacy, but they have typically a short follow-up and include only a limited number of patients, which rarely allows to assess safety appropriately. In addition, RCTs generally include highly selected patients and use strict protocols, which may not be representative of the challenges patients and health professionals face in real-life. By contrast, non-randomised studies, such as observational studies or epidemiological studies, have typically large numbers of patients, long follow-ups and highly heterogeneous study populations, which may allow to study subgroup of patients with different characteristics or establish generalisability in a less homogenous population. Therefore, real-world studies are increasingly recognised as an important mean to evaluate drug safety and effectiveness, and pharmaceutical companies are now more than ever required to demonstrate a real-life perspective in the regulatory process [...].

Keywords

  • Rheumatoid arthritis
  • Observational research
  • Epidemiology
  • Persistence
  • Retention
  • Drug

Citation (ISO format)

LAUPER, Kim, FINCKH, Axel. Predictive factors of treatment persistence in rheumatoid arthritis. In: Joint, Bone, Spine, 2020. doi: 10.1016/j.jbspin.2020.03.006

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

1297-319X
442views
764downloads

Technical informations

Creation

20/07/2020 14:30:00

First validation

20/07/2020 14:30:00

Update

13/10/2025 17:07:20

Status update

03/02/2025 12:53:56

Last indexation

21/08/2026 16:49:16
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated